July 21, 2009 Oncology

Big News in Cancer Treatment for Dogs!

Big News in Cancer Treatment for Dogs!

Just last month, veterinary oncology had a first and as a board certified veterinary oncologist, this news just made my day. Until now, all chemotherapy agents administered to dogs were human drugs adapted for use by veterinarians. In June, the Food and Drug Administration’s Center for Veterinary Medicine approved the use of Palladia® (toceranib phosphate) which was specifically developed for use in dogs and has safety and efficacy data from canine studies backing its use. Palladia is licensed for the treatment of recurrent mast cell tumors. Veterinary oncologists have effective therapies for some dogs with mast cell tumors. These treatments include surgery, human chemotherapy agents and radiation therapy. But not all dogs have tumors amenable to surgical removal, not all tumors are in a location where radiation therapy can be safely administered and currently available chemotherapy agents do not cure every dog. So the first drug specifically developed for canine mast cell tumors is big news. Mast cell tumors are one of the most common skin tumors in dogs and are one of the most important cancers veterinary oncologists treat. Some dogs are unlucky enough to have multiple mast cell tumors or a mast cell tumor that keeps coming back in the same location. So a drug to help manage this common tumor is big news, redux. Palladia belongs to a class of drugs known as tyrosine kinase inhibitors. The presence of abnormal tyrosine kinases in tumors results in the proliferation of tumor cells and the growth of new blood vessels to the tumor. These blood vessels provide nutrients to the growing tumor. Inhibition of tyrosine kinases by drugs like Pallada (or for humans, Gleevec®, another tyrosine kinase inhibitor) stops both cell proliferation and new blood vessel growth. Without nutrients and without cell proliferation the tumor shrinks. More big news. Pfizer Animal Health is working with veterinary specialists to help them use Palladia effectively and safely. It is currently available from board certified veterinary specialists in oncology, internal medicine and dermatology. To find the specialist nearest you go to https://www.acvim.org/ for oncologists and internists and at https://www.acvd.org/ for dermatologists. Pricing for Palladia has not yet been announced. Click here to download an information sheet about Palladia from The AMC.
The Oncology Team at The Animal Medical Center At The Animal Medical Center, specialists certified by the American College of Veterinary Internal Medicine in the sub-specialty of Oncology and the American College of Veterinary Radiology in the sub-specialty of Radiation Oncology provide dedicated care for pets with cancer Monday through Saturday. We take a team approach to cancer care, collaborating with specialists in the fields of diagnostic imaging, pathology, surgery and internal medicine to create a customized plan for the care of your pets.

Tags: ACVD, ACVIM, andrea flory, animal hospital, animal medical center, animals, ann hohenhaus, cancer dog, canine cancer, canine mast cell tumor, chemotherapy, dog, dogs, fatty tumor, FDA, gleevec, health, john farrelly, mast cell tumor, new york vet, nicole leibman, Oncology, palladia, pet, pet emergency, pet health, pet healthcare, pet insurance, pet owner, pets, pfizer animal health, skin tumor, tyrosine kinase inhibitor, Uncategorized, vet, veterinarian, veterinary care, veterinary internal medicine, veterinary oncology,

Related Posts

  • Dogs Pet Safety
    A dog sitting in the grass
    July 03, 2024

    Summer Food Hazards for Dogs

    Learn More
  • Dogs Responsible Pet Ownership
    May 29, 2024

    Keeping Your Dog Safe by the Pool [2024 Update]

    Learn More
  • Dogs Emergency
    A man walking two dogs in New York City
    March 20, 2024

    City Safety for Urban Dogs [2024 Update]

    Learn More